31
total announcements
SHALBY.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,358 Cr
P/E (TTM)
36.1
P/E (Forward)
13.4
EPS (TTM)
₹3.50
52W Low
₹125.82
52W High
₹254.95
Dividend Yield
0.00%
Beta
0.61
Price / Book
1.3
Debt / Equity
59.1
Revenue (TTM)
₹1,176 Cr
Gross Margin
23.88%
Operating Margin
6.90%
Shalby Limited
Shalby Limited has informed the Exchange about the withdrawal of suspension of registration of Shalby Hospital, Jabalpur, following a minor fire incident on October 11, 2026. The hospital is permitted to resume its normal operations, subject to certain conditions.
Shalby Limited
Shalby Limited has informed the Exchange about the suspension of registration of Shalby Hospital, Jabalpur, pending reassessment and submission of fire safety and electrical safety inspection reports after a minor fire incident.
Shalby Limited
Shalby Limited has informed the Exchange about a copy of newspaper publication for advance intimation for transfer of shares to IEPF.
Shalby Limited
Shalby Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization and rematerialization of securities for the quarter ended September 30, 2026.
Shalby Limited
Shalby Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from October 01, 2026, till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ended September 30, 2026.
Shalby Limited
Shalby Limited has informed the Exchange regarding Cessation of Mr. Shanay Vikram Shah as Additional Director designated as Whole-time Director of the company w.e.f. September 10, 2026.
Shalby Limited
Shalby Limited has submitted the voting results of its 22nd Annual General Meeting held on September 10, 2026, where resolutions 1 and 2 were passed with requisite majority, while resolutions 3 and 4 were not passed.
Shalby Limited
Shalby Limited held its 22nd Annual General Meeting on September 10, 2026, through video conferencing, where the company's performance and growth prospects were discussed. The meeting was conducted in accordance with applicable provisions of the Companies Act, 2013, and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. The company's audited financials for the financial year 2025-26 were presented, and the statutory auditors' report and secretarial auditor's report did not contain any qualifications or reservations.
Shalby Limited
Shalby Limited has informed the Exchange regarding the weblink letter to Shareholders whose email IDs are not registered intimating exact path of Annual Report FY 2025-26 and Notice of 22nd AGM.
Shalby Limited
Shalby Limited has released its Q1 FY 2027 earnings, showing a 11.6% year-on-year growth in consolidated revenues to ₹338.6 crores, with a PAT margin of 3.1%.
Shalby Limited
Shalby Limited has published a notice of its 22nd Annual General Meeting and e-voting information in the Financial Express newspaper.
Shalby Limited
Shalby Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Shalby Limited
Shalby Limited's Chief Executive Officer of Shalby Medtech Limited, Mr. Deepak Anand, has resigned effective September 4, 2026, to move abroad for personal reasons.
Shalby Limited
Shalby Limited has published a copy of newspaper publication relating to the pre-despatch notice of the 22nd Annual General Meeting (AGM) as per Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Shalby Limited
Shalby Limited has informed the Exchange about the link of the recording of the Earnings Conference Call held on August 13, 2026, to discuss Q1 FY 2027 earnings.
Shalby Limited
Shalby Limited has published unaudited financial results for the quarter ended June 30, 2026, with net profit at Rs. 250.66 crore and total income at Rs. 2,537.92 crore.
Shalby Limited
Shalby Limited has submitted an Investor Presentation for the quarter ended June 30, 2026, which includes financial and operational performance details. The presentation is being discussed at an Investor Conference call scheduled for August 13, 2026.
Shalby Limited
Shalby Limited has informed the Exchange about the grant of 15,000 Employee Stock Options (ESOP) under the Shalby Limited Employees Stock Options Scheme – 2021 to eligible employees.
Shalby Limited
Shalby Limited has informed the Exchange regarding the appointment of Mr. Shanay Vikram Shah as Additional Director designated as Whole-time Director for a term of five consecutive years, with effect from August 12, 2026. Mr. Shah is a relative of Dr. Vikram I. Shah, Promoter, Chairman and Managing Director of the Company, and has been associated with the Company since October 5, 2013. He holds a Bachelor's degree in Science with Honors in Accounting and Finance from the University of Warwick, United Kingdom, and a Master's degree in International Health Management from Imperial College London, United Kingdom. He is also a Chartered Financial Analyst (CFA).
Shalby Limited
Shalby Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and approved the appointment of Mr. Shanay Vikram Shah as a Whole-Time Director. The company also approved the acquisition of remaining 0.67% shares by Shalby Medtech Limited in Shalby Global Technologies Pte. Ltd. and the appointment of internal auditors.